Tag: GCP compliance

Data Flow Mapping: From Source to EDC, Safety and Statistical Outputs

Posted on By digi

Data Flow Mapping: From Source to EDC, Safety and Statistical Outputs Data Flow Mapping: From Source to EDC, Safety and Statistical Outputs In clinical trials, effective management and flow of data is paramount for successful outcomes and regulatory compliance. Data flow mapping plays a critical role in visualizing and optimizing processes from source data collection…

Read More “Data Flow Mapping: From Source to EDC, Safety and Statistical Outputs” »

Source Data & ALCOA++

ALCOA++ in Decentralized Trials: Wearables, Apps and Remote Assessments

Posted on By digi

ALCOA++ in Decentralized Trials: Wearables, Apps and Remote Assessments ALCOA++ in Decentralized Trials: Wearables, Apps and Remote Assessments The implementation of decentralized clinical trials (DCTs) represents a transformative approach in clinical research. The integration of innovative technologies, such as wearables, mobile applications, and remote assessments, fosters enhanced patient engagement and data collection. However, to ensure…

Read More “ALCOA++ in Decentralized Trials: Wearables, Apps and Remote Assessments” »

Source Data & ALCOA++

Training Sites and Vendors on Deviation Reporting Expectations

Posted on By digi

Training Sites and Vendors on Deviation Reporting Expectations Training Sites and Vendors on Deviation Reporting Expectations Clinical trials are essential in advancing medical knowledge and improving patient care. However, the success of these trials depends heavily on adhering to regulatory requirements, particularly in areas such as deviation reporting. This comprehensive tutorial provides a step-by-step guide…

Read More “Training Sites and Vendors on Deviation Reporting Expectations” »

Deviation/Incident Management

Handling Outstanding Deviations and Safety Follow-Up at Close-Out

Posted on By digi

Handling Outstanding Deviations and Safety Follow-Up at Close-Out Handling Outstanding Deviations and Safety Follow-Up at Close-Out In the lifecycle of a clinical trial, the close-out phase serves a critical function in ensuring the integrity of the study, compliance with regulatory requirements, and the safety of participants. The handling of outstanding deviations and ensuring effective safety…

Read More “Handling Outstanding Deviations and Safety Follow-Up at Close-Out” »

Close-Out Visits & Archiving

Archiving Requirements: Timelines, Formats and Access Controls

Posted on By digi

Archiving Requirements: Timelines, Formats and Access Controls In the realm of clinical research, adhering to archiving requirements is critical for regulatory compliance, data integrity, and protecting the interests of all stakeholders involved. This comprehensive guide delves into the essential aspects of archiving within the context of clinical trials, particularly focusing on timelines, formats, and access…

Read More “Archiving Requirements: Timelines, Formats and Access Controls” »

Close-Out Visits & Archiving

Handling Corrections, Late Entries and Addenda to Source Documents

Posted on By digi

Handling Corrections, Late Entries and Addenda to Source Documents The integrity of source documents in clinical trial services is essential for successful trial outcomes and compliance with regulatory requirements. This article provides a comprehensive, step-by-step tutorial on how to effectively manage corrections, late entries, and addenda to source documents within clinical trials. It targets clinical…

Read More “Handling Corrections, Late Entries and Addenda to Source Documents” »

Source Data & ALCOA++

Source Data Verification Strategies in Risk-Based Monitoring Models

Posted on By digi

Source Data Verification Strategies in Risk-Based Monitoring Models Source Data Verification Strategies in Risk-Based Monitoring Models In the dynamic landscape of clinical trials, particularly with the increasing implementation of Risk-Based Monitoring (RBM) strategies, the importance of effective Source Data Verification (SDV) cannot be overstated. This guide aims to provide clinical operations, regulatory affairs, and medical…

Read More “Source Data Verification Strategies in Risk-Based Monitoring Models” »

Source Data & ALCOA++

Integration of Deviation Data With CAPA, Risk and Audit Programs

Posted on By digi

Integration of Deviation Data With CAPA, Risk and Audit Programs Integration of Deviation Data With CAPA, Risk and Audit Programs In the landscape of clinical trials, managing deviations is a critical component of ensuring data integrity and maintaining compliance with regulatory standards. This tutorial provides a comprehensive, step-by-step guide to integrating deviation data with Corrective…

Read More “Integration of Deviation Data With CAPA, Risk and Audit Programs” »

Deviation/Incident Management

IP Return, Destruction and Documentation at Close-Out

Posted on By digi

IP Return, Destruction and Documentation at Close-Out IP Return, Destruction and Documentation at Close-Out Effective clinical trial management is essential for ensuring compliance with the various regulations set forth by organizations such as the FDA, EMA, and MHRA. One of the critical stages in the life cycle of clinical research is the close-out phase, which…

Read More “IP Return, Destruction and Documentation at Close-Out” »

Close-Out Visits & Archiving

Essential Documents and TMF Completeness Checks Before Site Closure

Posted on By digi

Essential Documents and TMF Completeness Checks Before Site Closure Essential Documents and TMF Completeness Checks Before Site Closure As clinical trials conclude, the integrity and completeness of documentation are paramount. Close-out visits and the archiving process require meticulous attention to ensure regulatory compliance, particularly for til therapy clinical trials and others involving pivotal medications like…

Read More “Essential Documents and TMF Completeness Checks Before Site Closure” »

Close-Out Visits & Archiving